Back to Screener

Healthcare

Medacta Group S.A.(MEDGF)

Live Price

Offline

$83.91

+0.00% today

Window Change

+0.00%

Window

Jun 23, 2025 โ†’ Apr 7, 2026

Market Cap
$1.67B
Revenue Growth
+16.5%
EPS Growth
+31.4%
Dividend Yield
0.5%
Partial coverage

Historical coverage is still expanding

This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.

Coverage: 199 bars ยท Jun 23, 2025 โ†’ Apr 7, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Medacta Group S.A. (MEDGF) is a Healthcare stock with a market cap of $1.67B and listed on OTC. The stock last traded around $83.91 and up 0.0% across the available one-year price window (Jun 23, 2025 โ†’ Apr 7, 2026). Baseline metrics include revenue growth of +16.5%, EPS growth of +31.4%, a dividend yield of 0.5%. What stands out right now is revenue +16.5%, EPS +31.4%, free cash flow +1119.0% with operating margin 16.9% and ROIC 11.9%. The dividend is present but secondary, with a yield around 0.5%. Valuation already assumes a fairly strong business story at P/E 32.5 and price/sales 4.5. Stock Foundry combines MEDGF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

MEDGF

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

MEDGF Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for MEDGF and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Medacta Group S.A. (MEDGF)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

Latest Revenue

โ€”

Latest Net Income

โ€”

Free Cash Flow

โ€”

Revenue Growth

+16.5%

EPS Growth

+31.4%

Gross Margin

67.1%

Net Margin

14.0%

No financial statement data available for MEDGF in annual view.

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.